DHODH and neuroblastoma: Importantly, dipyridamole treatment fully restored the sensitivity of neuroblastoma cell lines to DHODH inhibitors in the presence of 50% FBS, including GSK983 (Fig. 6D), BRQ (Fig. 6E), and leflunomide (Fig. S5A).